Faeth Therapeutics, Inc. (FTH) stock
FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.03−0.62 (-5.82%)
Close on Nov 13, 2026Market cap $259.18MP/E –Yield –
Faeth Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Faeth Therapeutics's price to book ratio was 2.0× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.2× to 4.9×, with a median of 0.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.0× | +1.4 |
| 2025 | Dec 31, 2025 | 0.6× | +0.3 |
| 2024 | Dec 31, 2024 | 0.3× | +0.0 |
| 2023 | Dec 29, 2023 | 0.2× | −0.2 |
| 2022 | Dec 30, 2022 | 0.4× | −0.7 |
| 2021 | Dec 31, 2021 | 1.1× | – |
See a number that looks wrong?